Strs Ohio Aadi Bioscience, Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.59 - $2.44 $236,751 - $363,316	148,900 Added 2256.06%	155,500 $363,000
Q4 2023 Jan 30, 2024	BUY	$1.97 - $5.41 $9,653 - $26,509	4,900 Added 288.24%	6,600 $13,000
Q3 2023 Oct 26, 2023	BUY	$4.84 - $7.13 $8,228 - $12,121	1,700 New	1,700 $8,000
Q3 2022 Oct 27, 2022	SELL	$12.03 - $14.22 $10,827 - $12,798	-900 Reduced 26.47%	2,500 $35,000
Q2 2022 Jul 25, 2022	BUY	$11.57 - $17.92 $39,338 - $60,928	3,400 New	3,400 $41,000

12.6M

23.8K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $46.7M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.